Proteinuria
7 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| ARBs in combination of SGLT2i for proteinuria | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Atrasentan for proteinuria | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Iptacopan for proteinuria | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| JADE101 for proteinuria | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Lorundrostat 25mg+SGLT2i QD, Washout, Placebo+SGLT2i QD for albuminuria | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Placebo + SOTAGLIFLOZIN for albuminuria | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Placebo QD + SGLT2i QD, Washout, Lorundrostat 25mg+SGLT2i QD for albuminuria | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |